An sanar da cewa allurar rigakafin Sinopharm ta kasar China tana da tasiri da kaso 72.8 cikin dari a kan sabon nau'in coronavirus (Kovid-19).
A cewar jaridar The National News, wani bincike da Jaridar kungiyar likitocin Amurka ta gudanar a kan masu aikin sa kai 40,832 daga Hadaddiyar Daular Larabawa, Bahrain, Masar da Jordan an gano iya yawan tasirin alluran rigakafin.
An yi wa masu sa kai allura tare da allurar rigakafin placebo, a makonni uku a tsakani.
A cikin binciken, an bayyana cewa allurar raiga kafin Sinopharm yana ba da kariya ta 72. cikin daga Kovid-19.